Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: Morning or evening administration

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 52, Issue 9, 2013, Pages 921-930

  Newcorn, Jeffrey H ^a   Stein, Mark A ^b   Childress, Ann C ^c   Youcha, Sharon ^d   White, Carla ^e   Enright, Gail ^f   Rubin, Jonathan ^f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Center for Psychiatry and Behavioral Medicine Inc   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e Shire Pharmaceuticals   (United Kingdom)

^f SHIRE   (United States)

Author keywords

2A agonist; attention deficit hyperactivity disorder (ADHD); guanfacine extended release (GXR); nonstimulant

Indexed keywords

GUANFACINE; PLACEBO;

ABDOMINAL CRAMP; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; CHILD; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RELEASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENURESIS; EVENING DOSAGE; FAINTNESS; FATIGUE; FEMALE; HUMAN; HYPERSOMNIA; INCREASED APPETITE; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SEDATION; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD); GUANFACINE EXTENDED RELEASE (GXR); NONSTIMULANT; Α(2A)-AGONIST;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COHORT STUDIES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GUANFACINE; HUMANS; MALE; PERSONALITY ASSESSMENT;

EID: 84883234638     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2013.06.006     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children - United States, 2003 and 2007 MMWR Morb Mortal Wkly Rep 59 2010 1439 1443
2. W.J. Barbaresi, S.K. Katusic, R.C. Colligan, A.L. Weaver, and S.J. Jacobsen Long-term school outcomes for children with attention-deficit/ hyperactivity disorder: a population-based perspective J Dev Behav Pediatr 28 2007 265 273
3. I.M. Loe, and H.M. Feldman Academic and educational outcomes of children with ADHD J Pediatr Psychol 32 2007 643 654
4. The MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder Arch Gen Psychiatry 56 1999 1073 1086
5. T.E. Wilens, and T.J. Spencer The stimulants revisited Child Adolesc Psychiatr Clin N Am 9 2000 573 603 viii
6. T. Banaschewski, V. Roessner, R.W. Dittmann, P.J. Santosh, and A. Rothenberger Non-stimulant medications in the treatment of ADHD Eur Child Adolesc Psychiatry 13 Suppl 1 2004 I102 I116
7. J. Lee, N. Grizenko, V. Bhat, S. Sengupta, A. Polotskaia, and R. Joober Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD BMC Psychiatry 11 2011 70
8. INTUNIV® (guanfacine) extended-release tablets [package insert]. Wayne, PA: Shire Pharmaceuticals LLC.
9. J. Biederman, R.D. Melmed, and A. Patel A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder Pediatrics 121 2008 e73 e84
10. F.R. Sallee, J. McGough, T. Wigal, J. Donahue, A. Lyne, and J. Biederman Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial J Am Acad Child Adolesc Psychiatry 48 2009 155 165
11. S.H. Kollins, R. Jain, and M. Brams Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD Pediatrics 127 2011 e1406 e1413
12. R.D. Hunt, R.B. Minderaa, and D.J. Cohen Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial J Am Acad Child Psychiatry 24 1985 617 629
13. R.D. Hunt, R.B. Minderaa, and D.J. Cohen The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate Psychopharmacol Bull. 22 1986 229 236
14. D.F. Connor, K.E. Fletcher, and J.M. Swanson A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder J Am Acad Child Adolesc Psychiatry 38 1999 1551 1559
15. R.D. Hunt, A.F. Arnsten, and M.D. Asbell An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder J Am Acad Child Adolesc Psychiatry 34 1995 50 54
16. R. Jain, S. Segal, S.H. Kollins, and M. Khayrallah Clonidine extended-release tablets for pediatric patients with attention-deficit/ hyperactivity disorder J Am Acad Child Adolesc Psychiatry 50 2011 171 179
17. Rubin J, Lopez FA, Youcha S. Impact of guanfacine extended release on cognitive problems and inattention. Poster presented at: 2010 Annual Meeting of the Society for Developmental and Behavioral Pediatrics Annual Meeting; September 11-14, 2010; Boston, MA.
18. Lopez FA, White C, Rubin J. Effects of guanfacine extended release on parent-reported behaviors in a randomized double-blind study of subjects with attention-deficit/hyperactivity disorder. Poster presented at: American Professional Society of ADHD and Related Disorders; November 5-6, 2010; Washington, DC.
19. J.H. Newcorn, S. Clerkin, K.P. Schulz, and J.M. Halperin Adrenergic agonists: Clonidine and guanfacine A. Martin, L. Scahill, D. Charney, J. Leckman, Textbook of Child and Adolescent Psychopharmacology Second Edition 2011 Oxford University Press New York, NY 263 274
20. T.E. Wilens, O. Bukstein, and M. Brams A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/ hyperactivity disorder J Am Acad Child Adolesc Psychiatry 51 2012 74 85
21. American Psychiatric Association Attention-deficit and disruptive behavior disorders. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR) 2000 American Psychiatric Association Washington, DC 85 93
22. G.J. DuPaul, T.J. Power, A.D. Anastopoulos, and R. Reid ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation 1998 Guilford Press New York, NY
23. S.L. Block, D. Kelsey, and D. Coury Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing Clin Pediatr (Phila) 48 2009 723 733